| Dr Porfirio Ernesto Diaz, MD | |
|
#1021 General Del Valle Urb. Delicias, San Juan, PR 00924-3722 | |
| (787) 731-2123 | |
| Not Available |
| Full Name | Dr Porfirio Ernesto Diaz |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 44 Years |
| Location | #1021 General Del Valle Urb. Delicias, San Juan, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992727713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 6921 (Puerto Rico) | Primary |
| Entity Name | Dr Porfirio Diaz Torres Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932827680 PECOS PAC ID: 9234597956 Enrollment ID: O20230627003291 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.2 million from the U.S. National Institute of General Medical Sciences of the National Institutes of Health to identify, test and develop a series of drug candidates for a number of diseases, including rheumatoid arthritis, heart disease and several neurodegenerative disorders.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Recent shortages of vaccines, most recently the flu vaccine during the past winter, are not short-term glitches-they reflect long-term problems in the vaccine industry. A variety of social, legal and economic forces have caused pharmaceutical companies to withdraw their commitment to vaccines, according to pediatrician and vaccine expert Paul A. Offit, M.D., chief of Infectious Diseases at The Children's Hospital of Philadelphia.
The "Elements" strategy - indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine introduced in 2013 - comes full circle with the introduction of automated stereotactic radiosurgery (SRS) planning tools. These new Elements enable on-the-fly generation of consistent treatment plans for VMAT delivery.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Porfirio Ernesto Diaz, MD #1021 General Del Valle Urb. Delicias, San Juan, PR 00924-3722 Ph: (787) 731-2123 | Dr Porfirio Ernesto Diaz, MD #1021 General Del Valle Urb. Delicias, San Juan, PR 00924-3722 Ph: (787) 731-2123 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.2 million from the U.S. National Institute of General Medical Sciences of the National Institutes of Health to identify, test and develop a series of drug candidates for a number of diseases, including rheumatoid arthritis, heart disease and several neurodegenerative disorders.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Recent shortages of vaccines, most recently the flu vaccine during the past winter, are not short-term glitches-they reflect long-term problems in the vaccine industry. A variety of social, legal and economic forces have caused pharmaceutical companies to withdraw their commitment to vaccines, according to pediatrician and vaccine expert Paul A. Offit, M.D., chief of Infectious Diseases at The Children's Hospital of Philadelphia.
The "Elements" strategy - indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine introduced in 2013 - comes full circle with the introduction of automated stereotactic radiosurgery (SRS) planning tools. These new Elements enable on-the-fly generation of consistent treatment plans for VMAT delivery.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 9 days ago
Dr. Antonio Luis Diaz Hernandez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1492 Ave La Constitucion Suite 717, Edificio Centro Europa, San Juan, PR 00907 Phone: 787-723-5017 | |
Reynerio E Perez Ramirez, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1492 Ave Ponce De Leon, Cond Centro Europa Suite 717, Cardiocare & Vascular Cen, San Juan, PR 00907 Phone: 787-723-5015 | |
Dr. Gilberto Rivera, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Torre Auxilio Mutuo Ponce De Leon Ave 735, Suite 408, San Juan, PR 00917 Phone: 787-227-0408 Fax: 787-229-0408 | |
Dr. Martha Yanetty Gomez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Carr 21 U 3 19, Las Lomas, San Juan, PR 00921 Phone: 787-775-0100 Fax: 787-775-0700 | |
Dr. Alberto T Lopez-enriquez, MD,FACP Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 431 Ave Ponce De Leon, Nacional Plaza Suite 900, San Juan, PR 00917 Phone: 787-751-2277 Fax: 787-751-2278 | |
Dr. Gregorio A. Cortes-soto, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1826 Ave Fernandez Juncos, San Juan, PR 00909 Phone: 787-726-8396 Fax: 787-727-6672 | |
Dr. Waldemar Charles Rios, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 400 Ave Domenech, Suite 607, San Juan, PR 00918 Phone: 787-250-0084 Fax: 787-250-2181 |